PER 6.67% 7.0¢ percheron therapeutics limited

results for atl1103..., page-182

  1. 605 Posts.
    lightbulb Created with Sketch. 3
    Think the next ANP is going to be CBZ.

    5% of shareholders got the votes from the majority to change the Board so they can now really move forward. The share price during the old board's tenure fell from 80c to 20c. And now Novo Nordisk a big pharma has the Phase II results and has first option to sign an agreement with CBZ. A few other pharma's also have the data and can make an offer with them. Novo has till mid Dec to exercise its offer. Expected offer in the range of $111mil.

    CBZ to move back into the 60-80c hopefully soon.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.